Severity of leukoaraiosis correlates with clinical outcome after ischemic stroke

Neurology

Volumn 72, Issue 16, 2009, Pages 1403-1410

  Arsava, E M ^b   Rahman, R ^b,c   Rosand, J ^b,c   Lu, J ^b   Smith, E E ^b   Rost, N S ^b,c   Singhal, A B ^b   Lev, M H ^b   Furie, K L ^b   Koroshetz, W J ^d   Sorensen, A G ^b   Ay, H ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^d NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE; GLUCOSE;

ADULT; AGED; ARTICLE; BRAIN INFARCTION; BRAIN INFARCTION SIZE; CEREBROVASCULAR ACCIDENT; CORRELATION ANALYSIS; DIABETES MELLITUS; DISEASE SEVERITY; FEMALE; GLUCOSE BLOOD LEVEL; HEART ATRIUM FIBRILLATION; HUMAN; HYPERTENSION; LEUKOARAIOSIS; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROGNOSIS; QUANTITATIVE ANALYSIS; RISK FACTOR; TREATMENT OUTCOME; AGE; BRAIN CORTEX; BRAIN ISCHEMIA; CLINICAL TRIAL; DISEASE COURSE; EPIDEMIOLOGY; HOSPITALIZATION; MIDDLE AGED; MULTICENTER STUDY; MYELINATED NERVE; PATHOLOGY; PATHOPHYSIOLOGY; PREDICTION AND FORECASTING; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; SEX DIFFERENCE; STROKE;

AGE FACTORS; AGED; AGED, 80 AND OVER; BRAIN ISCHEMIA; CAUSALITY; CEREBRAL CORTEX; DISEASE PROGRESSION; FEMALE; HUMANS; LEUKOARAIOSIS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NERVE FIBERS, MYELINATED; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SEX FACTORS; STROKE;

EID: 67449113713     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e3181a18823     Document Type: Article

References (39)

1. Slot KB, Berge E, Dorman P, Lewis S, Dennis M, Sandercock P. Oxfordshire Community Stroke Project, the International Stroke Trial (UK): Lothian Stroke Register: Impact of functional status at six months on long term survival in patients with ischaemic stroke: prospective cohort studies. BMJ 2008; 336:376-379.
2. Weimar C, König IR, Kraywinkel K, Ziegler A, Diener HC. German Stroke Study Collaboration: Age and National Institutes of Health Stroke Scale Score within 6 hours after onset are accurate predictors of outcome after cerebral ischemia: development and external validation of prognostic models. Stroke 2004;35:158-162.
3. Dombovy ML, Sandok BA, Basford JR. Rehabilitation for stroke: a review. Stroke 1986;17:363-369.
4. Basile AM, Pantoni L, Pracucci G, et al., LADIS Study Group. Age, hypertension, and lacunar stroke are the major determinants of the severity of age-related white matter changes: The LADIS (Leukoaraiosis and Disability in the Elderly) Study. Cerebrovasc Dis 2006;21:315-322.
5. Turner ST, Jack CR, Fornage M, Mosley TH, Boerwinkle E, de Andrade M. Heritability of leukoaraiosis in hypertensive sibships. Hypertension 2004;43:483-487.
6. Kuller LH, Longstreth WT Jr, Arnold AM, Bernick C, Bryan RN, Beauchamp NJ Jr. Cardiovascular Health Study Collaborative Research Group. White matter hyperintensky on cranial magnetic resonance imaging: a predictor of stroke. Stroke 2004;35:1821-1825.
7. Palumbo V, Boulanger JM, Hill MD, Inzitari D, Buchan AM, CASES Investigators. Leukoaraiosis and intracerebral hemorrhage after thrombolysis in acute stroke. Neurology 2007;68:1020-1024.
8. Henon H, Vroylandt P, Durieu I, Pasquier F, Leys D. Leukoaraiosis more than dementia is a predictor of stroke recurrence. Stroke 2003;34:2935-2940.
9. De Groot JC, De Leeuw FE, Oudkerk M, et al. Periventricular cerebral white matter lesions predict rate of cognitive decline. Ann Neurol 2002;52:335-341.
10. Ay H, Koroshetz WJ, Vangel M, et al. Conversion of ischemic brain tissue into infarction increases with age. Stroke 2005;36:2632-2636.
11. Ay H, Arsava EM, Rosand J, et al. Severity of leukoaraiosis and susceptibility to infarct growth in acute stroke. Stroke 2008;39:1409-1413.
12. Ay H, Benner T, Arsava EM, et al. A computerized algorithm for etiologic classification of ischemic stroke: the Causative Classification of Stroke System. Stroke 2007;38: 2979-2984.
13. Gurol ME, Irizarry MC, Smith EE, et al. Plasma beta-amyloid and white matter lesions in AD, MCI, and cerebral amyloid angiopathy. Neurology 2006;66:23-29.
14. Fazekas F, Barkhof F, Wahlund LO, et al. CT and MRI rating of white matter lesions. Cerebrovasc Dis 2002; 13 suppl 2:31-36.
15. Fisher CM. Binswanger's encephalopathy: a review. J Neurol 1989;236:65-79.
16. Tatu L, Moulin T, Bogousslavsky J, Duvernoy H. Arterial territories of the human brain: cerebral hemispheres. Neurology 1998;50:1699-1708.
17. Nandigam RN, Chen YW, Gurol ME, Rosand J, Greenberg SM, Smith EE. Validation of intracranial area as a surrogate measure of intracranial volume when using clinical MRI. J Neuroimaging 2007;17:74-77.
18. Ay H, Arsava EM, Vangel M, et al. Interexaminer difference in infarct volume measurements on MRI: a source of variance in stroke research. Stroke 2008;39:1171-1176.
19. Hartmann A, Rundek T, Mast H, et al. Mortality and causes of death after first ischemic stroke: the Northern Manhattan Stroke Study. Neurology 2001;57:2000-2005.
20. Streifler JY, Eliasziw M, Benavente OR, et al., North American Symptomatic Carotid Endarterectomy Trial Group. Prognostic importance of leukoaraiosis in patients with symptomatic internal carotid artery stenosis. Stroke 2002;33:1651-1655.
21. Leys D, Englund E, Del Ser T, et al. White matter changes in stroke patients: relationship with stroke subtype and outcome. Eur Neurol 1999;42:67-75.
22. Jorgensen HS, Nakayama H, Raaschou HO, Olsen TS. Leukoaraiosis in stroke patients: The Copenhagen Stroke Study. Stroke 1995;26:588-592.
23. Wahlund LO, Barkhof F, Fazekas F, et al., European Task Force on Age-Related White Matter Changes. A new rating scale for age-related white matter changes applicable to MRI and CT. Stroke 2001;32:1318-1322.
24. Saver JL. Number needed to treat estimates incorporating effects over the entire range of clinical outcomes: novel derivation method and application to thrombolytic therapy for acute stroke. Arch Neurol 2004;61:1066-1070.
25. Abciximab Emergent Stroke Treatment Trial (AbESTT) Investigators. Emergency administration of abciximab for treatment of patients with acute ischemic stroke: results of a randomized phase 2 trial. Stroke 2005;36:880-890.
26. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995;333: 1581-1587.
27. Moody DM, Thore CR, Anstrom JA, Challa VR, Langefeld CD, Brown WR. Quantification of afferent vessels shows reduced brain vascular density in subjects with leukoaraiosis. Radiology 2004;233:883-890.
28. O'Sullivan M, Lythgoe DJ, Pereira AC, et al. Patterns of cerebral blood flow reduction in patients with ischemic leukoaraiosis. Neurology 2002;59:321-326.
29. Heistad DD, Mayhan WG, Coyle P, Baumbach GL. Impaired dilatation of cerebral arterioles in chronic hypertension. BloodVessels 1990;27:258-262.
30. Grefkes C, Nowak DA, Eickhoff SB, et al. Cortical connectivity after subcortical stroke assessed with functional magnetic resonance imaging. Ann Neurol 2008;63:236-246.
31. Yamanouchi H, Sugiura S, Tomonaga M. Decrease in nerve fibres in cerebral white matter in progressive subcortical vascular encephalopathy of Binswanger type: an electron microscopic study. J Neurol 1989;236:382-387.
32. Ishihara M, Kumka S, Hayashi H, Kumazaki T. Loss of interhemispheric connectivity in patients with lacunar infarction reflected by diffusion-weighted MR imaging and single-photon emission CT. AJNR Am J Neuroradiol 1999;20:991-998.
33. Nordahl CW, Ranganath C, Yonelinas AP, Decarli C, Fletcher E, Jagust WJ. White matter changes compromise prefrontal cortex function in healthy elderly individuals. J Cogn Neurosci 2006;18:418-429.
34. Sinyor D, Amato P, Kaloupek DG, Becker R, Goldenberg M, Coopersmkh H. Post-stroke depression: relationships to functional impairment, coping strategies, and rehabilitation outcome. Stroke 1986;17:1102-1107.
35. Adams HP Jr, Davis PH, Leira EC, et al. Baseline NIH Stroke Scale score strongly predicts outcome after stroke: a report of the Trial of Org 10172 in Acute Stroke Treatment (TOAST). Neurology 1999;53:126-131.
36. Bath PM, Gray LJ, Collier T, Pocock S, Carpenter J, Optimising Analysis of Stroke Trials (OAST) Collaboration. Can we improve the statistical analysis of stroke trials? Statistical reanalysis of functional outcomes in stroke trials. Stroke 2007;38:1911-1915.
37. Buckley B, Murphy AW, Byrne M, Glynn L. Selection bias resulting from the requirement for prior consent in observational research: a community cohort of people with ischaemic heart disease. Heart 2007;93:1116-1120.
38. Kempen GI, van Sonderen E. Psychological attributes and changes in disability among low-functioning older persons: does attrition affect the outcomes? J Clin Epidemiol 2002;55:224-229.
39. Briley DP, Wasay M, Sergent S, Thomas S. Cerebral white matter changes (leukoaraiosis), stroke, and gait disturbance. J Am Geriatr Soc 1997;45:1434-1438.